Lan Y, Zhou S, Feng W, Qiao Y, Du X, Li F. Association of tumor mutation burden and epidermal growth factor receptor inhibitor history with survival in patients with metastatic stage III/IV nonsmall-cell lung cancer: A retrospective study. Clinics [Internet]. 2021 Nov. 9 [cited 2024 Jun. 30];76:e2251. Available from: https://revistas.usp.br/clinics/article/view/192286